Ortho-Clinical Diagnostics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Ortho-Clinical Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010880
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ortho-Clinical Diagnostics Inc (OCD) a subsidiary of The Carlyle Group L.P., is a provider of in vitro diagnostic products and services. The company designs, develops, manufactures and distributes in-vitro diagnostic products. It serves clinical laboratories by providing comprehensive solutions for screening, diagnosing, monitoring and confirming diseases early. It also serves the global transfusion medicine community by offering donor screening and blood typing products. The company’s services include e-connectivity, customer service and support, Ortho Plus SM services, product training and consulting services. The company has manufacturing facilities in Rochester, New York, Pompano Beach, Florida and Wales. The company offers its products and services in North America, Latin America, Europe and Asia Pacific. Ortho-Clinical is headquartered in Raritan, New Jersey, the US.

Ortho-Clinical Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Ortho-Clinical Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deal Details 11
Private Equity 11
Carlyle Group Completes Acquisition of Ortho-Clinical Diagnostics from Johnson & Johnson for up to USD4 Billion 11
Gores Completes Acquisition Of Therakos From Ortho-Clinical Diagnostics 13
Partnerships 14
Ortho-Clinical Diagnostics Enters into Agreement with Sphingotec 14
Ortho Clinical Diagnostics and EKF Diagnostic Enter into Agreement 15
Ortho Clinical Diagnostics Enters into Agreement with B·R·A·H·M·S 16
Wuhan Thalys Medical Tech Enters into Agreement with Ortho-Clinical Diagnostics 17
Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 18
Astute Medical Expands its Co-Marketing Agreement with Ortho-Clinical Diagnostics 20
Sphere Medical Enters into Co-Development Agreement with Ortho-Clinical Diagnostics for Proxima 4 21
Bristol-Myers Squibb, Saladax Biomedical And Ortho-Clinical Diagnostics Expand Co-Development Agreement 22
Rapid Biosensor Announces Option Agreement With Ortho-Clinical Diagnostics 23
Ortho-Clinical Diagnostics Inc – Key Competitors 24
Ortho-Clinical Diagnostics Inc – Key Employees 25
Ortho-Clinical Diagnostics Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Financial Announcements 28
Jul 26, 2017: Ortho Clinical Diagnostics to Present 10 Scientific Posters, Seven Products at AACC 28
Legal and Regulatory 30
Jun 26, 2017: Ortho Clinical Diagnostics Receives FDA 510(k) Clearance for Ortho’s VITROS Insulin Reagent & Calibrators 30
Product News 31
Oct 02, 2017: Ortho Clinical Diagnostics to Present Data on Automation in Immunohematology and Demonstrate Its Entire Transfusion Medicine Portfolio at the 2017 AABB Annual Meeting 31
Jun 20, 2017: Quotient and Ortho Clinical Diagnostics to Present Symposium on Role of Extended Phenotyping in Blood Matching at ISBT 32
Jun 12, 2017: Ortho Clinical Diagnostics to Present Data on Early Detection Of Acute Kidney Injury Risk, Immunoassay Development at EUROMEDLAB Athens 2017 33
Apr 04, 2017: Ortho Clinical Diagnostics to Present Data on Early Detection Of Acute Kidney Injury, Total Lab Automation and Transfusion Medicine at MEDLAB Asia Pacific 2017 34
Aug 09, 2016: Ortho Clinical Diagnostics Featured in Clinical Lab Products 35
Jul 25, 2016: Ortho Clinical Diagnostics to Present Seven Scientific Posters, Six Products at AACC 36
01/28/2016: Avioq Obtains Health Canada Approval for Screening of Cadaveric Organ and Tissue Donors with the Avioq HTLV-I/II Microelisa System, Expands Already Approved FDA and CE-IVD Claims 38
Product Approvals 39
Jan 28, 2016: Avioq Obtains Health Canada Approval for Screening of Cadaveric Organ and Tissue Donors with the Avioq HTLV-I/II Microelisa System, Expands Already Approved FDA and CE-IVD Claims 39
Other Significant Developments 40
Aug 02, 2016: Ortho Clinical Diagnostics Announces Ortho Care 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Ortho-Clinical Diagnostics Inc, Medical Equipment, Key Facts, 2015 2
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Ortho-Clinical Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Ortho-Clinical Diagnostics Inc, Deals By Market, 2011 to YTD 2017 9
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Carlyle Group Completes Acquisition of Ortho-Clinical Diagnostics from Johnson & Johnson for up to USD4 Billion 11
Gores Completes Acquisition Of Therakos From Ortho-Clinical Diagnostics 13
Ortho-Clinical Diagnostics Enters into Agreement with Sphingotec 14
Ortho Clinical Diagnostics and EKF Diagnostic Enter into Agreement 15
Ortho Clinical Diagnostics Enters into Agreement with B·R·A·H·M·S 16
Wuhan Thalys Medical Tech Enters into Agreement with Ortho-Clinical Diagnostics 17
Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 18
Astute Medical Expands its Co-Marketing Agreement with Ortho-Clinical Diagnostics 20
Sphere Medical Enters into Co-Development Agreement with Ortho-Clinical Diagnostics for Proxima 4 21
Bristol-Myers Squibb, Saladax Biomedical And Ortho-Clinical Diagnostics Expand Co-Development Agreement 22
Rapid Biosensor Announces Option Agreement With Ortho-Clinical Diagnostics 23
Ortho-Clinical Diagnostics Inc, Key Competitors 24
Ortho-Clinical Diagnostics Inc, Key Employees 25
Ortho-Clinical Diagnostics Inc, Other Locations 26
Ortho-Clinical Diagnostics Inc, Subsidiaries 27

★海外企業調査レポート[Ortho-Clinical Diagnostics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Standard Bank Group Ltd (SBK):企業の財務・戦略的SWOT分析
    Standard Bank Group Ltd (SBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • BioVectra Inc-製薬・医療分野:企業M&A・提携分析
    Summary BioVectra Inc (BioVectra), a subsidiary of Mallinckrodt Plc is a manufacturer and marketer of pharmaceutical ingredients. The company’s products include reducing reagents, bioprocessing reagents, molecular biology reagents, clinical diagnostic raw materials, high molecular weight vectra MPEG …
  • National Aerospace Fasteners Corporation:企業の戦略・SWOT・財務情報
    National Aerospace Fasteners Corporation - Strategy, SWOT and Corporate Finance Report Summary National Aerospace Fasteners Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • ORBCOMM Inc (ORBC):企業の財務・戦略的SWOT分析
    ORBCOMM Inc (ORBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Landmark Graphics Corp:企業の戦略的SWOT分析
    Landmark Graphics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Blue Dolphin Energy Co (BDCO):企業の財務・戦略的SWOT分析
    Summary Blue Dolphin Energy Co (Blue Dolphin) operates as an oil and gas company that refines and markets petroleum products. The company own and operate pipeline assets and have leasehold interests in oil and gas properties. It also acquires, develops and explores oil and gas properties. Blue Dolph …
  • Western Area Power Administration:企業の戦略的SWOT分析
    Western Area Power Administration - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Inivata Ltd:製品パイプライン分析
    Summary Inivata Ltd (Inivata) is a clinical cancer genomics company that utilizes the precision of circulating tumor DNA analysis to improve personalized healthcare in oncology. The company uses liquid biopsy platform, to identify and characterize ctDNA through a non-invasive blood test. Its liquid …
  • Ossur hf (OSSR):医療機器:M&Aディール及び事業提携情報
    Summary Ossur hf. (Ossur) is an orthopedic devices company. It develops, manufactures and sells prosthetics, and bracing and support products. The company’s key areas of expertise include silicone, carbon composites, mechatronics and textiles. Ossur offers ankle and foot supports, knee braces, neck …
  • Atriva Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Atriva Therapeutics GmbH (Atriva Therapeutics) is a developer of antiviral therapies that develops therapies against seasonal and pandemic influenza. The company develops ATR-001 drug candidate, a MEK inhibitor which targets influenza. It also offers repurposing existing MEK inhibitors, orig …
  • Borges International Group SLU:企業の戦略的SWOT分析
    Borges International Group SLU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Paysafe Group Plc:企業の戦略的SWOT分析
    Paysafe Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Secom Co Ltd.:企業の戦略・SWOT・財務分析
    Secom Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Secom Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Brake Bros Ltd:企業の戦略的SWOT分析
    Brake Bros Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Adept Technology, Inc.:企業の戦略的SWOT分析
    Adept Technology, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Daiichi Sankyo Co Ltd (4568):医療機器:M&Aディール及び事業提携情報
    Summary Daiichi Sankyo Company Ltd (Daiichi Sankyo) is a holding company that carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs, vaccines, and others. Its portfolio encompa …
  • Endo International Plc (ENDP):企業の財務・戦略的SWOT分析
    Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Definiens AG:医療機器:M&Aディール及び事業提携情報
    Summary Definiens AG (Definiens), a subsidiary of AstraZeneca Plc, is a healthcare technology company that offers image analysis and data mining solutions. The company offers products such as tissue studio, developer, image miner, server, architect and viewer, among others. Its services include cons …
  • National Real Estate Company K.S.C.:企業の戦略・SWOT・財務情報
    National Real Estate Company K.S.C. - Strategy, SWOT and Corporate Finance Report Summary National Real Estate Company K.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Bausch Health Companies Inc (BHC):企業の財務・戦略的SWOT分析
    Bausch Health Companies Inc (BHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆